STOCK TITAN

Silicon Labs (SLAB) director awarded 962 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Sadana Sumit reported acquisition or exercise transactions in this Form 4 filing.

SILICON LABORATORIES INC. director Sumit Sadana received a grant of 962 restricted stock units (RSUs) of common stock at no cash cost. Each RSU represents the right to receive one share of common stock.

The RSUs will vest in full on the earlier of the first anniversary of the grant date or one day before the company’s next Annual Meeting of Stockholders. After this award, Sadana directly holds 9,982 shares of Silicon Labs common stock, reflecting a modest, compensation-related increase in his equity stake.

Positive

  • None.

Negative

  • None.
Insider Sadana Sumit
Role null
Type Security Shares Price Value
Grant/Award Common Stock, $0.0001 par value 962 $0.00 --
Holdings After Transaction: Common Stock, $0.0001 par value — 9,982 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 962 shares Restricted stock units awarded to director
Price per share $0.0000 per share Grant/award acquisition, no cash paid
Shares held after award 9,982 shares Total direct holdings after RSU grant
Security type Common Stock, $0.0001 par value Underlying security for RSU award
restricted stock units (RSUs) financial
"Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Annual Meeting of Stockholders financial
"the date one day prior to the Annual Meeting of Stockholders in the year following"
transaction code "A" regulatory
"transaction_code": "A","transaction_type": "non-derivative""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sadana Sumit

(Last)(First)(Middle)
47544 AVALON HEIGHTS TERRACE

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SILICON LABORATORIES INC. [ SLAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.0001 par value04/23/2026A962(1)A$09,982D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. The RSUs will vest completely on the earlier of (i) the first (1st) anniversary of the date of grant, and (ii) the date one day prior to the Annual Meeting of Stockholders in the year following the grant date.
Remarks:
Saie-Yau Hui for Sumit Sadana04/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SILICON LABORATORIES INC. (SLAB) report for Sumit Sadana?

Silicon Laboratories reported that director Sumit Sadana received a grant of 962 restricted stock units (RSUs) of common stock. This is a compensation-related equity award, not an open-market purchase or sale, and increases his direct share holdings in the company.

How many RSUs did Sumit Sadana receive from Silicon Laboratories (SLAB)?

Sumit Sadana was granted 962 restricted stock units of Silicon Laboratories common stock. Each RSU entitles him to one share upon vesting. This award represents additional equity compensation rather than a cash transaction in the market.

When do Sumit Sadana’s new RSUs in Silicon Laboratories (SLAB) vest?

The 962 RSUs granted to Sumit Sadana will vest completely on the earlier of the first anniversary of the grant date or one day before Silicon Laboratories’ Annual Meeting of Stockholders in the following year, aligning vesting with the company’s governance calendar.

What is Sumit Sadana’s total Silicon Laboratories (SLAB) shareholding after this Form 4?

Following the grant of 962 RSUs, Sumit Sadana holds 9,982 shares of Silicon Laboratories common stock directly. This figure reflects his ownership after the reported award and shows the scale of his equity position in the company.

Was the Silicon Laboratories (SLAB) RSU grant to Sumit Sadana an open-market buy or sell?

No, the transaction was not an open-market buy or sell. It was a grant of 962 restricted stock units as compensation, recorded with transaction code “A” for award or other acquisition, and did not involve paying a purchase price per share.

What does each RSU granted to Sumit Sadana by Silicon Laboratories (SLAB) represent?

Each of the 962 RSUs granted to Sumit Sadana represents the right to receive one share of Silicon Laboratories common stock upon vesting. RSUs are a form of stock-based compensation that turns into actual shares once vesting conditions are satisfied.